Vinyltris(methylethylketoxime)silane

We are Vinyltris(methylethylketoxime)silane CAS:2224-33-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Vinyltris(methylethylketoxime)silane
CAS.NO:2224-33-1
Synonyms:O,O',O''-(Vinylsilanetriyl)tris(butan-2-one oxime);
Molecular Formula:C14H27N3O3Si
Molecular Weight:313.46800
 
Physical and Chemical Properties:
Density:0.990;
Melting point:oC;
Boiling point:115oC;
Flash point:63oC;
Index of Refraction:1.4635;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥97.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is used as a neutral curing agent in silicone sealant formulations. In most cases it is used in combination with methyloxime silane. Compared to formulations based on methyloxime silanes only, the use of combinations containing methyl-and vinyloxime silanes leads to a shorter skin formation time of the silicone sealant without a reduction of the curing time. The ability of the sealant to withstand stress early, required for a certain elasticity and tear resistance, is achieved.

Vinyltris(methylethylketoxime)silane


Related News: At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.Glycyrrhizic Acid Dipotassium Salt Hydrate CAS:68797-35-3 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.methyl (3S)-3-amino-3-phenylpropanoate,hydrochloride CAS:144494-72-4 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.1,9-decadieno CAS:1647-16-1 This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.

Related Products
Product Name
5-(2-ethylsulfanylpropyl)cyclohexane-1,3-dione View Details
N-[4-[4-(naphthalen-1-ylamino)phenyl]phenyl]naphthalen-1-amine View Details
3-Bromo-6-methoxy-2-methylpyridine View Details
2-Fluorophenol manufacturer 3,5-Difluoroanisole manufacturer 1,4-Diaminobenzene Dihydrochloride manufacturer (4-Isopropylphenyl)(p-tolyl)iodonium tetrakis(perfluorophenyl)borate Cas:178233-72-2 manufacturer 2-Butanethiol manufacturer